Cargando…

Culture-based antibiotic susceptibility testing for Helicobacter pylori infection: a systematic review

BACKGROUND: Primary antibiotic resistance in Helicobacter pylori (H. pylori) strains is increasing worldwide, affecting therapy success. The use of therapies tailored on susceptibility pre-testing at culture has been proposed, but data are still conflicting. METHOD: We performed a systematic review...

Descripción completa

Detalles Bibliográficos
Autores principales:	Francesco, Vincenzo De, Zullo, Angelo, Manta, Raffaele, Satriano, Alissa, Fiorini, Giulia, Pavoni, Matteo, Saracino, Ilaria M., Giostra, Fabrizio, Monti, Giorgio, Vaira, Dino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hellenic Society of Gastroenterology 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922261/ https://www.ncbi.nlm.nih.gov/pubmed/35479595 http://dx.doi.org/10.20524/aog.2022.0689

Ejemplares similares

Rescue Therapies for H. pylori Infection in Italy
por: De Francesco, Vincenzo, et al.
Publicado: (2021)

Next Generation Sequencing for the Prediction of the Antibiotic Resistance in Helicobacter pylori: A Literature Review
por: Saracino, Ilaria Maria, et al.
Publicado: (2021)

Trends in Primary Antibiotic Resistance in H. pylori Strains Isolated in Italy between 2009 and 2019
por: Saracino, Ilaria Maria, et al.
Publicado: (2020)

Newer agents for Helicobacter pylori eradication
por: Fiorini, Giulia, et al.
Publicado: (2012)

Antibiotic Resistance and Therapy for H. pylori Infection in Immigrant Patients Treated in Italy
por: Fiorini, Giulia, et al.
Publicado: (2020)

Antimicrobial Efficacy of Five Probiotic Strains Against Helicobacter pylori
por: Saracino, Ilaria Maria, et al.
Publicado: (2020)

The Effects of Two Novel Copper-Based Formulations on Helicobacter pylori
por: Saracino, Ilaria M., et al.
Publicado: (2013)

Antibiotic Resistance and Therapy Outcome in H. pylori Eradication Failure Patients
por: I.M., Saracino, et al.
Publicado: (2020)

First-line therapies for Helicobacter pylori eradication: a critical reappraisal of updated guidelines
por: De Francesco, Vincenzo, et al.
Publicado: (2017)

Helicobacter pylori infection and gastroesophageal cancer: unveiling a Hamletic dilemma
por: Zullo, Angelo, et al.
Publicado: (2014)

Paradigm shift: the Copernican revolution in diverticular disease
por: Zullo, Angelo, et al.
Publicado: (2019)

Helicobacter pylori culture: from bench to bedside
por: Zullo, Angelo, et al.
Publicado: (2022)

Clinical Performance of the Automated LIAISON® Meridian H. pylori SA Stool Antigen Test
por: Opekun, Antone R., et al.
Publicado: (2020)

Effectiveness of first and second‐line empirical treatment in Italy: Results of the European registry on Helicobacter pylori management
por: Gatta, Luigi, et al.
Publicado: (2022)

Antibiotic Resistance Prevalence and Trends in Patients Infected with Helicobacter pylori in the Period 2013–2020: Results of the European Registry on H. pylori Management (Hp-EuReg)
por: Bujanda, Luis, et al.
Publicado: (2021)

Helicobacter pylori and portal hypertensive gastropathy: any new information?
por: Zullo, Angelo, et al.
Publicado: (2014)

The role of the occupational physician in controlling gastric cancer attributable to Helicobacter pylori infection: A review
por: Collatuzzo, Giulia, et al.
Publicado: (2021)

Furazolidone-based Therapies for Helicobacter pylori Infection: A Pooled-data Analysis
por: Zullo, Angelo, et al.
Publicado: (2012)

Preliminary considerations regarding the risk of COVID-19 and disease severity in chronic gastrointestinal conditions
por: Piciucchi, Matteo, et al.
Publicado: (2020)

Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy
por: Gatta, Luigi, et al.
Publicado: (2013)

Endoscopic submucosal dissection for gastric lesions
por: Manta, Raffaele, et al.
Publicado: (2023)

Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg)
por: Nyssen, Olga P., et al.
Publicado: (2022)

Helicobacter pylori Diagnostic Tests Used in Europe: Results of over 34,000 Patients from the European Registry on Helicobacter pylori Management
por: García-Morales, Natalia, et al.
Publicado: (2023)

First- and second-line Helicobacter pylori eradication with modified sequential therapy and modified levofloxacin-amoxicillin-based triple therapy
por: Zullo, Angelo, et al.
Publicado: (2014)

Evaluation of Susceptibility of the Human Pathogen Helicobacter pylori to the Antibiotic Capreomycin
por: Sukati, Suriyan, et al.
Publicado: (2022)

Antibiotic Resistance, Susceptibility Testing and Stewardship in Helicobacter pylori Infection
por: Ng, Ho-Yu, et al.
Publicado: (2023)

Increased susceptibility to Helicobacter pylori infection in pregnancy.
por: Lanciers, S, et al.
Publicado: (1999)

Asymptomatic Anisakis and erosive lesions in the colon
por: Zullo, Angelo, et al.
Publicado: (2018)

Antibiotic susceptibility, heteroresistance, and updated treatment strategies in Helicobacter pylori infection
por: Mascellino, Maria Teresa, et al.
Publicado: (2017)

Comparison of the management of Helicobacter pylori infection between the older and younger European populations
por: Jonaitis, Paulius, et al.
Publicado: (2023)

High-dose esomeprazole and amoxicillin dual therapy for first-line Helicobacter pylori eradication: a proof of concept study
por: Zullo, Angelo, et al.
Publicado: (2015)

Laboratory diagnosis and susceptibility profile of Helicobacter pylori infection in the Philippines
por: Destura, Raul V, et al.
Publicado: (2004)

Antimicrobial susceptibility of Canadian isolates of Helicobacter pylori in Northeastern Ontario
por: Eng, Nelson F, et al.
Publicado: (2015)

The impact of host's genetic susceptibility on Helicobacter pylori infection in children
por: Mărginean, Maria Oana, et al.
Publicado: (2017)

Susceptibility-guided therapy for Helicobacter pylori infection treatment failures
por: Yu, Lou, et al.
Publicado: (2019)

Is Only Clarithromycin Susceptibility Important for the Successful Eradication of Helicobacter pylori?
por: Kim, Young Min, et al.
Publicado: (2020)

In Vitro Activity of Sertraline, an Antidepressant, Against Antibiotic-Susceptible and Antibiotic-Resistant Helicobacter pylori Strains
por: Krzyżek, Paweł, et al.
Publicado: (2019)

Antibiotic Susceptibility Profile of Helicobacter pylori Isolated from the Dyspepsia Patients in Tehran, Iran
por: Shokrzadeh, Leila, et al.
Publicado: (2011)

Changes in Antibiotic Susceptibility of Helicobacter pylori in the Course of Eight Years in the Zaanstreek Region in The Netherlands
por: Loffeld, R. J. L. F., et al.
Publicado: (2013)

Efficacy of Tegoprazan for Improving the Susceptibility of Antimicrobial Agents against Antibiotic-Resistant Helicobacter pylori
por: Lee, Jung Won, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gad6i5ftjfsdq0p7j56esqrlp4